147 related articles for article (PubMed ID: 37843781)
1. ANXA3, associated with YAP1 regulation, participates in the proliferation and chemoresistance of cervical cancer cells.
Huang J; Wei W; Kang F; Tan S; Li Y; Lu X; Wang N
Genes Genomics; 2023 Dec; 45(12):1575-1586. PubMed ID: 37843781
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.
Du R; Liu B; Zhou L; Wang D; He X; Xu X; Zhang L; Niu C; Liu S
Cell Death Dis; 2018 Jan; 9(2):126. PubMed ID: 29374148
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
Kim JY; Jung EJ; Park HJ; Lee JH; Song EJ; Kwag SJ; Park JH; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC
Clin Breast Cancer; 2018 Aug; 18(4):e713-e719. PubMed ID: 29217453
[TBL] [Abstract][Full Text] [Related]
4. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
Pan QZ; Pan K; Weng DS; Zhao JJ; Zhang XF; Wang DD; Lv L; Jiang SS; Zheng HX; Xia JC
Mol Carcinog; 2015 Aug; 54(8):598-607. PubMed ID: 24375474
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.
Wang L; Li X; Ren Y; Geng H; Zhang Q; Cao L; Meng Z; Wu X; Xu M; Xu K
Cancer Sci; 2019 May; 110(5):1609-1620. PubMed ID: 30868675
[TBL] [Abstract][Full Text] [Related]
6. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
7. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis
Guo C; Li N; Dong C; Wang L; Li Z; Liu Q; Ma Q; Greenaway FT; Tian Y; Hao L; Liu S; Sun MZ
J Adv Res; 2021 May; 30():85-102. PubMed ID: 34026289
[TBL] [Abstract][Full Text] [Related]
8. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
Xu R; Yin J; Zhang Y; Zhang S
J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
[TBL] [Abstract][Full Text] [Related]
9. Expression and significance of Annexin A3 in the osteosarcoma cell lines HOS and U2OS.
Zeng X; Wang S; Gui P; Wu H; Li Z
Mol Med Rep; 2019 Sep; 20(3):2583-2590. PubMed ID: 31524248
[TBL] [Abstract][Full Text] [Related]
10. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984
[No Abstract] [Full Text] [Related]
11. Annexin A3 Knockdown Suppresses Lung Adenocarcinoma.
Liu YF; Liu QQ; Zhang YH; Qiu JH
Anal Cell Pathol (Amst); 2016; 2016():4131403. PubMed ID: 27995049
[TBL] [Abstract][Full Text] [Related]
12. Microglial Annexin A3 promoted the development of melanoma via activation of hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway.
Xu B; Zhang X; Gao Y; Song J; Shi B
J Clin Lab Anal; 2021 Feb; 35(2):e23622. PubMed ID: 33118214
[TBL] [Abstract][Full Text] [Related]
13. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3.
Wan X; Guo D; Zhu Q; Qu R
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G309-G322. PubMed ID: 32463333
[TBL] [Abstract][Full Text] [Related]
14. Annexin A3 is necessary for parallel artery-vein alignment in the mouse retina.
Huang K; Crist AM; Patel NR; Blanks A; Carter K; Cleaver O; Meadows SM
Dev Dyn; 2020 May; 249(5):666-678. PubMed ID: 32020697
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of annexin A3 promotes ionizing radiation-induced EGFR activation and nuclear translocation and confers radioresistance in nasopharyngeal carcinoma.
Yang L; Lu P; Yang X; Li K; Chen X; Zhou Y; Qu S
Exp Cell Res; 2022 Sep; 418(2):113292. PubMed ID: 35850266
[TBL] [Abstract][Full Text] [Related]
16. ANXA3 deletion inhibits the resistance of lung cancer cells to oxaliplatin.
Jin YF; Huang YT; Chen PF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3741-3748. PubMed ID: 32329851
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.
Wang K; Li J
Oncotarget; 2016 Dec; 7(52):86972-86984. PubMed ID: 27894078
[TBL] [Abstract][Full Text] [Related]
18. The expression of ANXA3 and its relationship with the occurrence and development of breast cancer.
Zhou T; Liu S; Yang L; Ju Y; Li C
J BUON; 2018; 23(3):713-719. PubMed ID: 30003741
[TBL] [Abstract][Full Text] [Related]
19. MiR‑221 and miR‑222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3.
Kim JY; Jung EJ; Kim JM; Son Y; Lee HS; Kwag SJ; Park JH; Cho JK; Kim HG; Park T; Jeong SH; Jeong CY; Ju YT
Exp Ther Med; 2023 Mar; 25(3):127. PubMed ID: 36845963
[TBL] [Abstract][Full Text] [Related]
20. LncRNA EBLN3P Facilitates Osteosarcoma Metastasis by Enhancing Annexin A3 mRNA Stability and Recruiting HuR.
Wang S; Zeng X; Gui P; Xu S; Li Z; Chen D
Ann Surg Oncol; 2023 Dec; 30(13):8690-8703. PubMed ID: 37598115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
